Clinical value of mean platelet volume for impaired cardiopulmonary function in very old male patients with chronic obstructive pulmonary disease

Archives of Gerontology and Geriatrics

Volumn 54, Issue 2, 2012, Pages

  Cui, Hua ^a   Liu, Lin ^a   Wei, Zhimin ^a   Wang, Delong ^a   Hu, Yixin ^a   Hu, Guoliang ^a   Fan, Li ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Chronic obstructive pulmonary disease; Impaired cardiopulmonary function; Mean platelet volume; Very old male patients

Indexed keywords

ADULT; ARTERY DIAMETER; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY INSUFFICIENCY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LUNG FUNCTION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY ARTERY; THROMBOCYTE VOLUME;

AGED, 80 AND OVER; BLOOD PLATELETS; ELECTROCARDIOGRAPHY; FORCED EXPIRATORY VOLUME; HEART; HEMATOLOGIC TESTS; HUMANS; LINEAR MODELS; LUNG; MALE; PLATELET ACTIVATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STROKE VOLUME;

MOROCCAN PEPPER VIRUS;

EID: 84857044328     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2011.09.013     Document Type: Article

References (26)

1. Alper A.T., Akyol A., Hasdemir H., Yildirim A., Nurkalem Z., Guvenc T.S., Cakmak N., Oguz E., Erdinler I.C., Gurkan K. Effect of cardiac resynchronization therapy on mean platelet volume. Acta Cardiol. 2008, 63:735-739. (PubMed:19157169).
2. Cordova C., Musca A., Violi F., Alessandri C., Perrone A., Balsano F. Platelet hyperfunction in patients with chronic airways obstruction. Eur. J. Respir. Dis. 1985, 66:9-12. (PubMed:2579841).
3. Curkendall S.M., DeLuise C., Jones J.K., Lanes S., Stang M.R., Goehring E., She D. Cardiovascular disease in patients with chronic obstructive pulmonary disease Saskatchewan Canada cardiovascular disease in COPD patients. Ann. Epidemiol. 2006, 16:63-70. (PubMed:16039877).
4. Davi G., Basili S., Vieri M., Cipollone F., Santarone S., Alessandri C., Gazzaniga P., Cordova C., Violi F. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease The Chronic Obstructive Bronchitis and Haemostasis Study Group. Am. J. Respir. Crit. Care Med. 1997, 156:1794-1799. (PubMed:9412557).
5. De Castro J., Hernandez-Hernandez A., Rodriguez M.C., Sardina J.L., Llanillo M., Sanchez-Yague J. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma. Platelets 2007, 18:43-51. (PubMed:17365853).
6. Ferroni P., Basili S., Martini F., Vieri M., Labbadia G., Cordova C., Alessandri C., Gazzaniga P.P. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J. Invest. Med. 2000, 48:21-27. (PubMed:10695266).
7. Giles H., Smith R.E., Martin J.F. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur. J. Clin. Invest. 1994, 24:69-72. (PubMed:8187810).
8. Global Strategy for the Diagnosis, 2009. Management and prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic obstructive Lung Disease (GOLD). http://www.goldcopd.com/.
9. Halbert R.J., Natoli J.L., Gano A., Badamgarav E., Buist A.S., Mannino D.M. Global burden of COPD: systematic review and meta-analysis. Eur. Respir. J. 2006, 28:523-532. (PubMed:16611654).
10. Hardie J.A., Vollmer W.M., Buist A.S., Bakke P., Morkve O. Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Respir. Med. 2005, 99:186-195. (PubMed:15715185).
11. Hekimsoy Z., Payzin B., Ornek T., Kandogan G. Mean platelet volume in type 2 diabetic patients. J. Diabetes Complications 2004, 18:173-176. (PubMed:15145330).
12. Kandis H., Ozhan H., Ordu S., Erden I., Caglar O., Basar C., Yalcin S., Alemdar R., Aydin M. The prognostic value of mean platelet volume in decompensated heart failure. Emerg. Med. J. 2010 Jul 26., (PubMed:20660896).
13. Kostrubiec M., Labyk A., Pedowska-Wloszek J., Hrynkiewicz-Szymanska A., Pacho S., Jankowski K., Lichodziejewska B., Pruszczyk P. Mean platelet volume predicts early death in acute pulmonary embolism. Heart 2009, 96Kostrubiec:460-465. (PubMed:19910287).
14. Lopez A.D., Murray C.C. The global burden of disease, 1990-2020. Nat. Med. 1998, 4:1241-1243. (PubMed:9809543).
15. Maclay J.D., McAllister D.A., Johnston S., Raftis J., McGuinnes C., Deans A., Newby D.E., Mills N.L., Macnee W. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011, 66:769-774. (PubMed:21507906).
16. McQuillan B.M., Picard M.H., Leavitt M., Weyman A.E. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001, 104:2797-2802. (PubMed:11733397).
17. Ordu S., Ozhan H., Caglar O., Alemdar R., Basar C., Yazici M., Erden I. Mean platelet volume in patients with dipper and non-dipper hypertension. Blood Press 2010, 19:26-30. (PubMed:19929284).
18. Park Y., Schoene N., Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002, 13:301-306. (PubMed:12189016).
19. Patrono C. Thromboxane synthesis inhibitors and receptor antagonists. Thromb. Res. Suppl. 1990, 11:15-23. (PubMed:2148990).
20. Ponicke K., Sternitzky R., Mest H.J. Stimulation of aggregation and thromboxane A2 formation of human platelets by hypoxia. Prostaglandins Leukot. Med. 1987, 29:49-59. (PubMed:3478738).
21. Rajala U.M., Keinanen-Kiukaanniemi S.M., Hirsso P.K., Jokelainen J.J., Laakso M.A., Hiltunen L.A., Ruokonen A.O., Harkonen P.K., Timonen M.J. Associations of total testosterone and sex hormone-binding globulin levels with insulin sensitivity in middle-aged Finnish men. Diabetes Care 2007, 30:e13. (PubMed:17392528).
22. Rutten F.H., Cramer M.J., Lammers J.W., Grobbee D.E., Hoes A.W. Heart failure chronic obstructive pulmonary disease: an ignored combination?. Eur. J. Heart Fail. 2006, 8:706-711. (PubMed:16531114).
23. Semenov A.V., Kogan-Ponomarev M., Ruda M., Komarov A.L., Panchenko E.P., Chazova I.E., Mazurov A.V. Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension. Ter. Arkh. 2000, 72:15-20. (PubMed:10833791).
24. Varol E., Uysal B.A., Ozaydin M. Platelet indices in patients with pulmonary arterial hypertension. Clin. Appl. Thromb. Hemost. 2011, (PubMed:21406414).
25. Vizioli L., Muscari S., Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int. J. Clin. Pract. 2009, 63:1509-1515. (PubMed:19769707).
26. Wanger J., Clausen J.L., Coates A., Pedersen O.F., Brusasco V., Burgos F., Casaburi R., Crapo R., Enright P., van der Grinten C.P., Gustafsson P., Hankinson J., Jensen R., Johnson D., Macintyre N., McKay R., Miller M.R., Navajas D., Pellegrino R., Viegi G. Standardisation of the measurement of lung volumes. Eur. Respir. J. 2005, 26:511-522. (PubMed:16135736).